Saturday 17 October 2026 Export URGN’s income statement to Excel — free account

Urogen Pharma

Urogen Pharma’s revenue for fiscal 2025 (year ended December 2025) was $109.8 million, up 21.4% from fiscal 2024. In the quarter to June 2026, revenue grew 199.2%, EPS grew 73.3%, free cash flow grew 17.3% and total debt rose 56.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

34.56 2.05 −5.60%

Follow URGN

Alert me

Market cap: $1.8B
P/E: 0.0×
Fwd P/E: −30.0×
Dividend yield: —
F-score: 2/9
Altman Z: −5.16
Beneish M: −1.42
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		9.93	10.26	6.42	9.82
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(22.68)	(29.40)	(19.91)	(56.17)
P/B ratio Full definition →		0.00	0.00	0.00	0.00
Price to Tangible BV Full definition →		0.00	0.00	0.00	0.00
EV/Sales Full definition →		9.87	10.30	6.76	10.26
EV/EBITDA Full definition →		0.00	0.00	0.00	0.00
EV/Operating CF Full definition →		(6.92)	(6.96)	(5.73)	(12.18)
EV/FCF Full definition →		(6.90)	(6.95)	(5.72)	(12.17)
Quick Ratio Full definition →		3.51	3.34	3.89	3.20
Current Ratio Full definition →		3.99	4.01	4.69	3.80
Net Debt/EBITDA Full definition →		0.22	(0.20)	(2.38)	505.33
Debt/Assets Full definition →		65.99%	62.70%	74.71%	75.88%
Debt/Equity Full definition →		(1.06)	(1.19)	(1.53)	(1.45)
Asset Turnover Full definition →		0.40	0.45	0.56	0.82
Operating CF/Net income Full definition →		1.27	1.45	1.92	2.30
Capex/Depreciation Full definition →		0.05	0.00	(0.53)	(1.15)
Interest Coverage Full definition →		(8.12)	(5.07)	(4.84)	0.02
Research and Development Expense of Revenue Full definition →		50.97%	37.83%	30.61%	23.93%
Selling, General and Administrative Expense of Revenue Full definition →		136.75%	104.00%	101.03%	66.85%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		11.01%	8.27%	9.08%	7.36%
Graham Net Nets Full definition →		(0.14)	(0.11)	(0.16)	(0.08)
Graham Number Full definition →		13.67	12.56	12.38	10.82
Earnings Yield Full definition →		(17.34%)	(13.66%)	(15.29%)	(5.38%)
Free Cash Flow Yield Full definition →		(14.41%)	(14.44%)	(18.40%)	(8.58%)
Revenue per Share Full definition →		0.57	0.79	1.02	1.44
Operating CF per Share Full definition →		(0.88)	(0.80)	(0.90)	(0.66)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(0.88)	(0.80)	(0.90)	(0.66)
Cash per Share Full definition →		2.67	2.53	2.82	2.17
Shareholders Equity per Share Full definition →		(2.40)	(2.19)	(2.48)	(2.63)
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		(2.40)	(2.19)	(2.48)	(2.63)
Free Cash Flow Full definition →		(42.36)	(38.34)	(45.37)	(33.07)
Working Capital Full definition →		126.30	139.61	186.83	173.51
Capital Expenditures Full definition →		(0.09)	(0.02)	(0.05)	(0.06)
Net Current Asset Value Full definition →		(131.91)	(119.90)	(140.48)	(149.56)
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		21.25	26.69	37.53	54.20
Average Payables Full definition →		22.93	27.57	32.83	35.45
Average Inventory Full definition →		7.97	12.85	14.26	15.86
Average Assets Full definition →		243.49	243.08	250.65	230.65
Average Common Equity Full definition →		(44.95)	(57.14)	(85.36)	(112.89)

Fold the line items

Columns are period end dates

Stockrow Weekly